Delivery Order SPE2DB24D1006-SPE2DB24FCEKA
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.77, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. This contract award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,788.81 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,351.73, is a Firm Fixed Price Delivery Order for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,235.88, is for the supply of 180 mg Mestinon Timespan medication. The contract is a firm fixed-price delivery order with a completion date of March 27, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,963.15 firm-fixed-price contract is for the supply of Mestinon 180 mg Timespan medication. This delivery order falls under a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which provides a wide range of pharmaceutical and medical supplies to military treatment facilities and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mestinon 180 mg Timespan medication, with a ceiling value of $9,806.66 and a period of performance ending on June 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $18,070.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. It has an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $16,589.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 14, 2025 and was not set aside for any specific business category. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $14,300.14 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is between the Defense Logistics Agency (DLA) and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $3,067.81 firm-fixed-price delivery order is for the provision of 180 capsules of the drug Mesalamine DR 400 mg. The contract has an ultimate completion date of November 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive...